Back to Search
Start Over
Golcadomide (GOLCA; CC-99282), a Novel CELMoD Agent, Plus R-CHOP in Patients (pts) with Previously Untreated Aggressive B-Cell Lymphoma (a-BCL): Safety and Efficacy Results from Phase 1b Dose Expansion
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p4459-4459, 1p
- Publication Year :
- 2023
-
Abstract
- Introduction
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64705544
- Full Text :
- https://doi.org/10.1182/blood-2023-174242